Cytopathological characteristics of pleural effusion in diagnosis of mediastinal diffuse large B-cell lymphoma

doi:10.19401/j.cnki.1007-3639.2020.09.012

Welcome to China Oncology,

China Oncology ›› 2020, Vol. 30 ›› Issue (9): 712-717.doi: 10.19401/j.cnki.1007-3639.2020.09.012

• Short Article • Previous Articles Next Articles

Cytopathological characteristics of pleural effusion in diagnosis of mediastinal diffuse large B-cell lymphoma

QIN Lingyan ¹ , GUO Lingchuan ¹ , GU Dongmei ¹ , YU Jie ¹ , YOU Zhiqun ¹, HE Lu ²

1. Department of Pathology, The First Affiliated Hospital of Soochow University, Suzhou 215006, Jiangsu Province, China; 2. Department of Imaging, The First Affiliated Hospital of Soochow University, Suzhou 215006, Jiangsu Province, China

Online:2020-09-30 Published:2020-10-13
Contact: GUO Lingchuan E-mail: qlyzmm@163.com

Share article

Abstract

QIN Lingyan , GUO Lingchuan , GU Dongmei , YU Jie , YOU Zhiqun , HE Lu . Cytopathological characteristics of pleural effusion in diagnosis of mediastinal diffuse large B-cell lymphoma[J]. China Oncology, 2020, 30(9): 712-717.

[1]	LIN Jiaxin, WEI Ran, SHUI Ruohong, LU Hongfen, LI Xiaoqiu, YU Baohua. Clinicopathological analysis of adrenal intravascular large B-cell lymphoma [J]. China Oncology, 2024, 34(11): 1020-1027.
[2]	WEI Jing, HE Yaqi, XUE Tian, BAI Qianming, SHUI Ruohong, LU Hongfen, LI Xiaoqiu, YU Baohua. Clinicopathological analysis of DLBCL/HGBL with MYC, BCL2 and BCL6 gene rearrangement [J]. China Oncology, 2023, 33(9): 809-817.
[3]	CHEN Guangliang, WU Fangtian, CAO Junning. Advances in research on EBV positive diffuse large B-cell lymphoma, not otherwise specified [J]. China Oncology, 2022, 32(3): 258-267.
[4]	LI Panpan, ZHANG Zhuo. Analysis of prognostic factors in 42 cases of primary central nervous system lymphoma [J]. China Oncology, 2021, 31(12): 1194-1201.
[5]	ZHANG Yan, TANG Yong, YAO Yiyun, ZOU Lifang, DOU Hongju, ZHU Qi. Retrospective analytical study on clinical features and prognostic models in patients with head and neck diffuse large B-cell lymphoma [J]. China Oncology, 2020, 30(6): 449-455.
[6]	WANG Ping, YANG Wenxiu, ZHOU Jie, FENG Jianglong, LIN Chaoqun. The correlation of NF-κB/p65, PD-1 and PD-L1 expressions and their clinical significance in diffuse large B-cell lymphoma [J]. China Oncology, 2020, 30(5): 375-382.
[7]	GE Xiaowen, YAO Jiamei, ZHU Na, LUAN Lijuan, GAO Feng, ZENG Haiying, JI Yuan, TAN Yunshan, HOU Yingyong. Expression and clinical implication of calreticulin in diffuse large B-cell lymphoma [J]. China Oncology, 2020, 30(5): 347-354.
[8]	SUN Yangyang,GENG Xiang,ZHOU Xiaoli,WANG Gengfang,GU Wenxian,ZHANG Xudong . Clinicopathologic observation and prognostic factor analysis of primary gastric diffuse large B-cell lymphoma [J]. China Oncology, 2019, 29(9): 715-722.
[9]	YU Baohua, XUE Tian, ZHANG Yan, et al. MYD88 gene mutation in diffuse large B-cell lymphoma and its clinicopathological relevance [J]. China Oncology, 2018, 28(9): 679-685.
[10]	FAN Yan-lan, LI Xiao-qiu. Reevaluation of predictive biomarkers of diffuse large B-cell lymphoma in the rituximab era [J]. China Oncology, 2013, 23(6): 467-471.

Cytopathological characteristics of pleural effusion in diagnosis of mediastinal diffuse large B-cell lymphoma

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 10

Recommended Articles

Metrics

Comments